Evommune (EVMN) Interest & Investment Income (2024 - 2026)
Evommune (EVMN) reported Interest & Investment Income of $2.3 million for Q1 2026, up 272.59% year-over-year from $613000.0 in Q1 2025, and up 58.28% quarter-over-quarter from $1.4 million in Q4 2025.
Evommune (EVMN) Interest & Investment Income (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Interest & Investment Income data on file, last reported at $2.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $2.3 million, up 272.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (changed N/A YoY), and the FY2025 annual result was $3.3 million, up 2.5% from the prior year.
- Interest & Investment Income advanced to $2.3 million in Q1 2026 per EVMN's latest filing, from $1.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.3 million in Q1 2026 and troughed at $613000.0 in Q1 2025.
- A 3-year average of $1.1 million and a median of $794500.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income surged 39.48% in 2025, then surged 272.59% in 2026.
- A 3-year view of Interest & Investment Income shows it stood at $727000.0 in 2024, then surged by 98.49% to $1.4 million in 2025, then jumped by 58.28% to $2.3 million in 2026.
- Business Quant data shows EVMN's Interest & Investment Income at $2.3 million in Q1 2026, $1.4 million in Q4 2025, and $862000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | 2.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.28 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 862,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 727,000.00 |
| Sep 30, 2024 | 618,000.00 |